deha.us.comDeha Pharmaceuticals, LLC – Fluid retention and prevention of accumulation of fluid
deha.us.com Profile
deha.us.com
Maindomain:us.com
Title:Deha Pharmaceuticals, LLC – Fluid retention and prevention of accumulation of fluid
Description:Skip to content OUR COMPANY OUR SCIENCE TEAM LATEST NEWS CONTACT US Revolutionary medicine targeting basic cellular transport mechanism LARGE HEMISPHERIC STROKE RESULTS IN BRAIN EDEMA Our research at
Discover deha.us.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
deha.us.com Information
Website / Domain: |
deha.us.com |
HomePage size: | 24.011 KB |
Page Load Time: | 0.225392 Seconds |
Website IP Address: |
162.213.253.19 |
Isp Server: |
Namecheap Inc. |
deha.us.com Ip Information
Ip Country: |
United States |
City Name: |
Atlanta |
Latitude: |
33.727291107178 |
Longitude: |
-84.42537689209 |
deha.us.com Keywords accounting
deha.us.com Httpheader
Date: Tue, 10 Mar 2020 15:11:47 GMT |
Server: Apache |
X-Powered-By: PHP/5.6.40 |
Link: http://www.deha.us.com/wp-json/; rel="https://api.w.org/", http://www.deha.us.com/; rel=shortlink |
Vary: Accept-Encoding |
Content-Encoding: gzip |
Content-Length: 6314 |
Content-Type: text/html; charset=UTF-8 |
deha.us.com Meta Info
charset="utf-8"/ |
content="width=device-width, initial-scale=1" name="viewport"/ |
content="WordPress 4.9.13" name="generator" |
content="http://www.deha.us.com/wp-content/uploads/2017/12/DehaLogoWithoutNamequare-1-300x300.png" name="msapplication-TileImage" |
162.213.253.19 Domains
deha.us.com Similar Website
Domain |
WebSite Title |
deha.us.com | Deha Pharmaceuticals, LLC – Fluid retention and prevention of accumulation of fluid |
zuchepharma.trustpass.alibaba.com | ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices |
aeriepharma.com | Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals |
lifelinepharm.tracktracerx.com | Lifeline Pharmaceuticals, LLCâs Login Page | Lifeline Pharmaceuticals, LLC |
toolkit.ahpnet.com | Recruitment & Retention - Home |
pennfoster.getset.com | GetSet - Improve your retention, guaranteed |
old.autopoint.com | Auto Point - One Voice for Customer Retention |
academy.3rnet.org | 3RNET RECRUITING FOR RETENTION ACADEMY - Home |
source2.com | Source2 - Recruiting and Retention of Frontline Employees |
autopoint.com | AutoPoint – Maximum Retention. Minimal Effort. |
starfishsolutions.com | Starfish Retention Solutions | Start to Finish |
perfectretention.com | Reliable Document Storage in NY & NJ l Perfect Retention |
intellum.com | Increase Revenue & Improve Customer Retention | Intellum |
subscribe.cleeng.com | Subscriber Retention Management for OTT services - Cleeng |
info.perkville.com | Increase Retention & Referrals - Join Our Rewards Program |
deha.us.com Traffic Sources Chart
deha.us.com Alexa Rank History Chart
deha.us.com Html To Plain Text
Skip to content OUR COMPANY OUR SCIENCE TEAM LATEST NEWS CONTACT US Revolutionary medicine targeting basic cellular transport mechanism LARGE HEMISPHERIC STROKE RESULTS IN BRAIN EDEMA Our research at glance Reversing brain damage caused by fluid accumulation BIOLOGY OF AQUAPORINS Our research at glance Unlocking novel ways to target rare (Orphan) disease Neuromyelitis Optica (NMO) Our research at glance Prevalence of stroke is predicted to increase by 20.5% from 2012-2030 Our research at glance Cerebral edema in large hemispheric infarction (LHI), a deadly form of stroke with a mortality rate of up to 80% Our research at glance MOVING SCIENCE FORWARD OUR SCIENCE Novel compounds targeting key driver of edema in several clinical indications Aquaporin 4 (AQP4) inhibitors based on novel structure-based inhibitor design PARTNERING Our relationships with our partners allow us to build prospective pipelines as well as evaluate new technologies that augment our discovery and development initiatives. OUR PIPELINE Screening campaign yielded multiple highly potent AQP4 inhibitors Compounds have opportunity to treat several edema-related disorders © 2018 DEHA PHARMACEUTICAL, LLC. | ALL RIGHTS RESERVED ....
deha.us.com Whois
"domain_name": [
"US.COM",
"us.com"
],
"registrar": "Instra Corporation Pty Ltd.",
"whois_server": "whois.instra.net",
"referral_url": null,
"updated_date": "2018-09-24 19:13:19",
"creation_date": "1993-01-05 05:00:00",
"expiration_date": "2026-01-04 05:00:00",
"name_servers": [
"NS1.CENTRALNIC.NET",
"NS2.CENTRALNIC.NET",
"NS3.CENTRALNIC.NET",
"NS4.CENTRALNIC.NET",
"ns1.centralnic.net",
"ns2.centralnic.net",
"ns3.centralnic.net",
"ns4.centralnic.net"
],
"status": [
"clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited",
"clientTransferProhibited https://icann.org/epp#clientTransferProhibited",
"clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited"
],
"emails": [
"abuse@instra.com",
"info@domain-contact.org"
],
"dnssec": "signedDelegation",
"name": "REDACTED FOR PRIVACY",
"org": "REDACTED FOR PRIVACY",
"address": "REDACTED FOR PRIVACY",
"city": "REDACTED FOR PRIVACY",
"state": "REDACTED FOR PRIVACY",
"zipcode": "REDACTED FOR PRIVACY",
"country": "REDACTED FOR PRIVACY"